http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22127946

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article
endingPage 152
issn 1476-5829
1476-5810
issueIdentifier 2
pageRange 138-152
publicationName Veterinary and Comparative Oncology
startingPage 138
bibliographicCitation Rassnick KM, Bailey DB, Russell DS, Flory AB, Kiselow MA, Intile JL, Malone EK, Balkman CE, Barnard SM. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Vet Comp Oncol. 2010 Jun;8(2):138–52. doi: 10.1111/j.1476-5829.2010.00217.x. PMID: 20579327.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94029db09c8679939016df7e4f32e7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_590a3891188eae2312547925c21cce7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f04b1e5ea00db74297f41f3884f90ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a7902e27e12a9870e6450143f63ebc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdc760da54e8678aac58295a408ad5ae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b9cf0b617dc390b3fb266eb366a823c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb6989dd5bdcae8d38508b1f45c85ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31c9a2def4c9221e149acc2d0a3368bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_838db9fb52e3c925fa5c4b454f0d16d7
date 201006
identifier https://pubmed.ncbi.nlm.nih.gov/20579327
https://doi.org/10.1111/j.1476-5829.2010.00217.x
isPartOf https://portal.issn.org/resource/ISSN/1476-5810
https://portal.issn.org/resource/ISSN/1476-5829
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35529
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours
discusses http://id.nlm.nih.gov/mesh/M0028300
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0012676
http://id.nlm.nih.gov/mesh/M0022672
http://id.nlm.nih.gov/mesh/M0001486
http://id.nlm.nih.gov/mesh/M0028268
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D018931Q000008
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D014747Q000008
http://id.nlm.nih.gov/mesh/D018906Q000008
http://id.nlm.nih.gov/mesh/D008415Q000662
http://id.nlm.nih.gov/mesh/D004283Q000188
http://id.nlm.nih.gov/mesh/D011241Q000008
http://id.nlm.nih.gov/mesh/D000972Q000008
http://id.nlm.nih.gov/mesh/D008130Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008415Q000473
http://id.nlm.nih.gov/mesh/D008415Q000188
http://id.nlm.nih.gov/mesh/D018931Q000009
http://id.nlm.nih.gov/mesh/D000971Q000009
http://id.nlm.nih.gov/mesh/D014747Q000009
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D009503Q000139
http://id.nlm.nih.gov/mesh/D004283Q000473
http://id.nlm.nih.gov/mesh/D004285
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008130Q000009
http://id.nlm.nih.gov/mesh/D009503Q000662
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D011241Q000009
http://id.nlm.nih.gov/mesh/D009367
http://id.nlm.nih.gov/mesh/D018906Q000009
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D000972Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127993436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631

Total number of triples: 83.